Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1995 1
1996 2
1997 3
1998 1
1999 3
2000 1
2001 2
2002 2
2004 1
2005 4
2006 3
2008 1
2009 2
2010 2
2011 2
2012 2
2013 3
2014 1
2015 3
2016 3
2017 4
2018 3
2019 4
2020 3
2021 1
Text availability
Article attribute
Article type
Publication date

Search Results

50 results
Results by year
Filters applied: . Clear all
Page 1
Tumour initiating cells and IGF/FGF signalling contribute to sorafenib resistance in hepatocellular carcinoma.
Tovar V, Cornella H, Moeini A, Vidal S, Hoshida Y, Sia D, Peix J, Cabellos L, Alsinet C, Torrecilla S, Martinez-Quetglas I, Lozano JJ, Desbois-Mouthon C, Solé M, Domingo-Domenech J, Villanueva A, Llovet JM. Tovar V, et al. Among authors: desbois mouthon c. Gut. 2017 Mar;66(3):530-540. doi: 10.1136/gutjnl-2015-309501. Epub 2015 Dec 11. Gut. 2017. PMID: 26658144 Free PMC article.
Non-coding RNAs open a new chapter in liver cancer treatment.
Gougelet A, Desbois-Mouthon C. Gougelet A, et al. Among authors: desbois mouthon c. Clin Res Hepatol Gastroenterol. 2019 Nov;43(6):630-637. doi: 10.1016/j.clinre.2019.07.005. Epub 2019 Aug 7. Clin Res Hepatol Gastroenterol. 2019. PMID: 31401041 Free article. Review.
Targeting STAT3 in hepatocellular carcinoma: sorafenib again….
Rosmorduc O, Desbois-Mouthon C. Rosmorduc O, et al. Among authors: desbois mouthon c. J Hepatol. 2011 Nov;55(5):957-9. doi: 10.1016/j.jhep.2011.06.005. Epub 2011 Jun 28. J Hepatol. 2011. PMID: 21718664 Free article. No abstract available.
Potentials of CRISPR in liver research and therapy.
Loesch R, Desbois-Mouthon C, Colnot S. Loesch R, et al. Among authors: desbois mouthon c. Clin Res Hepatol Gastroenterol. 2019 Feb;43(1):5-11. doi: 10.1016/j.clinre.2018.05.001. Epub 2018 Jun 5. Clin Res Hepatol Gastroenterol. 2019. PMID: 29884474
c-myc-induced hepatocarcinogenesis in the absence of IGF-I receptor.
Cadoret A, Desbois-Mouthon C, Wendum D, Leneuve P, Perret C, Tronche F, Housset C, Holzenberger M. Cadoret A, et al. Among authors: desbois mouthon c. Int J Cancer. 2005 Apr 20;114(4):668-72. doi: 10.1002/ijc.20805. Int J Cancer. 2005. PMID: 15609331 Free article.
High IGF1R protein expression correlates with disease-free survival of patients with stage III colon cancer.
Zaanan A, Calmel C, Henriques J, Svrcek M, Blons H, Desbois-Mouthon C, Merabtene F, Goumard C, Parc Y, Gayet B, Taieb J, Validire P, Louvet C, Fléjou JF, Le Bouc Y, Praz F. Zaanan A, et al. Among authors: desbois mouthon c. Cell Oncol (Dordr). 2020 Apr;43(2):237-247. doi: 10.1007/s13402-019-00484-6. Epub 2019 Dec 10. Cell Oncol (Dordr). 2020. PMID: 31823290 Free article.
50 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page